Vancheswaran Gopalakrishnan

2016–2025 年に発表

32
論文数
23,615
被引用数
27
h 指数
31
i10 指数

被引用数

Vancheswaran Gopalakrishnan の年別被引用数1989 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 4 件2009 年: 被引用 1 件2015 年: 被引用 2 件2016 年: 被引用 5 件2017 年: 被引用 81 件2018 年: 被引用 265 件2019 年: 被引用 932 件2020 年: 被引用 1,624 件2021 年: 被引用 2,028 件2022 年: 被引用 1,916 件2023 年: 被引用 1,653 件2024 年: 被引用 2,205 件2025 年: 被引用 1,421 件2026 年: 被引用 59 件1990〜2004 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません2010〜2014 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,450 件、この内訳の 24.7%中国: 引用元論文 3,087 件、この内訳の 22.1%イタリア: 引用元論文 626 件、この内訳の 4.5%イギリス: 引用元論文 593 件、この内訳の 4.2%ドイツ: 引用元論文 558 件、この内訳の 4%フランス: 引用元論文 544 件、この内訳の 3.9%オーストラリア: 引用元論文 434 件、この内訳の 3.1%カナダ: 引用元論文 363 件、この内訳の 2.6%オランダ: 引用元論文 356 件、この内訳の 2.6%日本: 引用元論文 355 件、この内訳の 2.5%スペイン: 引用元論文 319 件、この内訳の 2.3%スイス: 引用元論文 246 件、この内訳の 1.8%
0%24.7%その他 21.7%

分野

  • Medicine47.4%
  • Biochemistry, Genetics and Molecular Biology36.1%
  • Immunology and Microbiology11.4%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.7%
  • Dentistry0.6%
  • その他2.4%

トピック

  • Cancer Immunotherapy and Biomarkers14%
  • Gut microbiota and health10%
  • Immunotherapy and Immune Responses5.6%
  • Immune Cell Function and Interaction4.5%
  • CAR-T cell therapy research4%
  • Immune cells in cancer3.3%
  • その他58.6%

共著者

全論文

検索で開く
  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo C. Okhuysen, V. Behrana Jensen, Alton G. Swennes, Florencia McAllister, Erick Riquelme, Yexi Zhang, Emmanuelle Le Chatelier, Laurence Zitvogel, Nicolas Pons, Jacob L. Austin-Breneman, Lauren E. Haydu, Elizabeth M. Burton, Julie M. Gardner, Elizabeth Sirmans, Jiemiao Hu, Alexander J. Lazar, Takahiro Tsujikawa, Adi Diab, Hussein A. Tawbi, Isabella C. Glitza, Wen-Jen Hwu, Sapna P. Patel, Scott E. Woodman, Rodabe N. Amaria, Michael A. Davies, Jeffrey E. Gershenwald, Patrick Hwu, J. E. Lee, J. Zhang, Lisa M. Coussens, Zachary A. Cooper, P. Andrew Futreal, Carrie R. Daniel, Nadim J. Ajami, Joseph F. Petrosino, Michael T. Tetzlaff, Padmanee Sharma, James P. Allison, Robert R. Jenq, Jennifer A. Wargo - Science 2017 被引用: 4,788

  2. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisa A. Rozeman, Christian U. Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R. Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda‐Shnaidman, Einav Nili Gal‐Yam, Hagit Shapira, Nicola Baldini, Morgan G. I. Langille, Alon Ben‐Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust‐Katz, Iris Barshack, Daniel S. Peeper, Dan J. Raz, Eran Segal, Jennifer A. Wargo, Judith Sandbank, Noam Shental, Ravid Straussman - Science 2020 被引用: 2,471

  3. B cells and tertiary lymphoid structures promote immunotherapy response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 被引用: 2,745

  4. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 被引用: 2,103

  5. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman - Science 2017 被引用: 1,812

  6. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 被引用: 932

  7. The microbiome, cancer, and cancer therapy

    著者: , , , , - Nature Medicine 2019 被引用: 1,220

  8. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

    著者: , , , , - Cancer Cell 2018 被引用: 1,363

  9. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 被引用: 721

  10. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khalida Wani, Alexander J. Lazar, Michael T. Tetzlaff, Courtney W. Hudgens, Margaret K. Callahan, Matthew Adamow, Michael A. Postow, Charlotte E. Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C. Pezo, Lauren E. Haydu, Julie M. Simon, Hussein A. Tawbi, Jennifer L. McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N. Amaria, Elizabeth M. Burton, Scott E. Woodman, Stephanie S. Watowich, Adi Diab, Sapna P. Patel, Isabella C. Glitza, Michael K.K. Wong, Li Zhao, Jianhua Zhang, Nadim J. Ajami, Joseph F. Petrosino, Robert R. Jenq, Michael A. Davies, Jeffrey E. Gershenwald, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A. Wargo - Nature Medicine 2021 被引用: 415

  11. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodabe N. Amaria, Lawrence N. Kwong, Víctor G. Prieto, R. Eric Davis, Wencai Ma, Willem W. Overwijk, Arlene H. Sharpe, Jianhua Hu, P. Andrew Futreal, Jorge Blando, Padmanee Sharma, James P. Allison, Lynda Chin, Jennifer A. Wargo - Cancer Discovery 2016 被引用: 1,008

  12. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 被引用: 826

  13. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott E. Woodman, Rodabe N. Amaria, Víctor G. Prieto, Jianhua Hu, Padmanee Sharma, James P. Allison, Lynda Chin, Jianhua Zhang, Jennifer A. Wargo, P. Andrew Futreal - Science Translational Medicine 2017 被引用: 920

  14. The gut microbiota influences anticancer immunosurveillance and general health

    著者: , , , , , - Nature Reviews Clinical Oncology 2018 被引用: 504

  15. Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 117

  16. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charl Verwey, Mark T. Esser, David E. Tabor, Louis Bont, Pascale Marro Clément, Atul Gupta, Koichi Hashimoto, Kseniya Komissarova, Matt Laubscher, Magali Santos Lumertz, Elena Priante, Irene Rivero‐Calle, Ushma Wadia, Ki Wook Yun - The Lancet Infectious Diseases 2023 被引用: 105

  17. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 被引用: 248

  18. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy

    著者: , , , , - Trends in Immunology 2018 被引用: 97

  19. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2019 被引用: 133

  20. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 被引用: 290

  21. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)

    著者: , , , , , , , , , , , , , , , , , , , , - Neoplasia 2022 被引用: 51

  22. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William N. William, Stephen G. Swisher, John V. Heymach, Harlan Robins, J. Jack Lee, Padmanee Sharma, James P. Allison, P. Andrew Futreal, Ignacio I. Wistuba, Jianjun Zhang - Cancer Discovery 2017 被引用: 236

  23. Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen

    著者: , , , , , , , , , , - Microorganisms 2021 被引用: 40

  24. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 被引用: 104